Alzheimer's Disease

The Alzheimer's Disease pipeline: 114 tracked drugs, 4 approved for this indication.

4 approved / phase 415 Phase 39 Phase 2/338 Phase 210 Phase 1/235 Phase 13 preclinical / unstaged

Compare the share prices of listed companies in Alzheimer's Disease →

Total attributable cost

$207.8B

$28,078/patient

Drug spend

Not yet sourced

How this is calculated ↗

All stages (2026 estimate) · US

The Alzheimer's Disease pipeline

Key trial results for every approved and late-stage drug: Alzheimer's Disease results by drug.

← all assets